[HTML][HTML] Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis

L Mu, X Sun, M Tu, D Zhang - Reproductive Biology and Endocrinology, 2021 - Springer
Background Genetic, environmental and epigenetical factors may play important roles in the
pathogenesis of polycystic ovary syndrome (PCOS), however the etiology of PCOS remains …

[HTML][HTML] Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis

R Deswal, AS Dang - Fertility and sterility, 2020 - Elsevier
Objective To investigate the clinical diagnostic value and role of micro-RNAs (miRNAs) in
the pathogenesis of polycystic ovary syndrome (PCOS). Design Systematic review and meta …

microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndrome

M Tamaddon, M Azimzadeh… - Journal of cellular and …, 2022 - Wiley Online Library
Polycystic ovary syndrome (PCOS) is known as the most common metabolic/endocrine
disorder among women of reproductive age. Its complicated causality assessment and …

[HTML][HTML] Characterization of altered microRNAs related to different phenotypes of polycystic ovarian syndrome (PCOS) in serum, follicular fluid, and cumulus cells

HM Rad, SJ Mowla, F Ramazanali… - Taiwanese Journal of …, 2022 - Elsevier
Objective Polycystic ovarian syndrome (PCOS) is a metabolic syndrome in which
steroidogenesis, folliculogenesis, and cellular adhesion play crucial roles in its prognosis …

[HTML][HTML] MicroRNAs related to polycystic ovary syndrome (PCOS)

AE Sørensen, ML Wissing, S Salö, ALM Englund… - Genes, 2014 - mdpi.com
Polycystic ovary syndrome (PCOS) is the most common, though heterogeneous, endocrine
aberration in women of reproductive age, with high prevalence and socioeconomic costs …

miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): a review

M Abdalla, H Deshmukh, SL Atkin, T Sathyapalan - Life Sciences, 2020 - Elsevier
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in females of
the reproductive age. PCOS is commonly manifested as ovulatory dysfunction, clinical and …

MicroRNA species in follicular fluid associating with polycystic ovary syndrome and related intermediary phenotypes

AE Sørensen, ML Wissing, ALM Englund… - The Journal of …, 2016 - academic.oup.com
Context: Polycystic ovary syndrome (PCOS) has a largely unknown etiology and presents
with a clinical heterogeneous patient group. Small noncoding microRNA (miRNA) might …

Role of microRNA in the pathogenesis of polycystic ovary syndrome

Z Chen, H Ou, H Wu, P Wu, Z Mo - DNA and cell biology, 2019 - liebertpub.com
Polycystic ovary syndrome (PCOS) is the most typical metabolic syndrome in women of
reproductive age, with a high prevalence and an increased risk of long-term complications …

[HTML][HTML] Aberrant expression of long non-coding RNAs in exosomes in follicle fluid from PCOS patients

L Wang, H Fan, Y Zou, Q Yuan, X Hu, X Chen… - Frontiers in …, 2021 - frontiersin.org
Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease
characterized by persistent anovulation and hyperandrogenism, affecting approximately 8 …

Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance

L Lin, T Du, J Huang, LL Huang, DZ Yang - Chinese medical journal, 2015 - mednexus.org
Background: Polycystic ovary syndrome (PCOS) is the commonest endocrinopathy in
women of reproductive age. The patients often develop insulin resistance (IR) or …